Vitamin D deficiency in cancer patients and predictors for screening (D-ONC study)

Alkan A., Koksoy E. B.

CURRENT PROBLEMS IN CANCER, vol.43, no.5, pp.421-428, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.1016/j.currproblcancer.2018.12.008
  • Journal Name: CURRENT PROBLEMS IN CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.421-428
  • Keywords: Vitamin D deficiency, Risk factors, Prevalence, 25(OH) D, Cancer, PROSTATE-CANCER, BREAST-CANCER, 25-HYDROXYVITAMIN-D, PREVENTION, HEALTH, RISK
  • Ankara University Affiliated: No

Abstract

Introduction: Vitamin D is a prohormone that is vital for calcium/phosphate balance, bone structure, and physiological functioning. Vitamin D deficiency (VDD) is an important clinical problem worldwide. However, there are no standardized protocols for screening of patients with a diagnosis of cancer. The purpose of this study is to define the prevalence of VDD in cancer patients and establish the predictors of VDD to address a specific group of patient for screening.